Traphagen Investment Advisors’s Avantis US Equity ETF AVUS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVUS
HWM
ORL
MPW
AAS
PCIA
Traphagen Investment Advisors's AVUS Position: Q2 2026 in Review
Traphagen Investment Advisors reduced its Avantis US Equity ETF (AVUS) stake by 3.6% in Q2 2026, selling an estimated $4.68M and leaving 1,015,751 shares worth $130M. The position accounts for 9.29% of the portfolio, ranked #2.
Traphagen Investment Advisors first reported a position in AVUS in Q3 2023 and has held it in 12 quarters since. The position peaked at $140M in Q4 2025. 398 funds tracked by Wall St. Rank hold AVUS as of Q2 2026.
- Traphagen Investment Advisors held 1,015,751 shares of Avantis US Equity ETF worth $130M as of Q2 2026.
- Traphagen Investment Advisors sold 37,993 Avantis US Equity ETF shares in Q2 2026, an estimated $4.68M.
- Avantis US Equity ETF made up 9.29% of Traphagen Investment Advisors's portfolio in Q2 2026, its #2 holding.
- Traphagen Investment Advisors first reported a position in Avantis US Equity ETF in Q3 2023 and has held it in 12 quarters since.
- Traphagen Investment Advisors's Avantis US Equity ETF position peaked at $140M in Q4 2025.
- 398 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q2 2026.
Based on Traphagen Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.